This transiently impairs early stages of memory formation, which can be reversed by compounds that increase cholinergic tone such as the cholinesterase inhibitors used for the treatment of mild-to-moderate Alzheimer’s disease [52]. This evidence concerns the gene BCHE and Alzheimer disease.